Clinical Trials Browser

magrolimab × 90 days × Clear all

NCT04435691 2026-04-23

Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Phase 1/2 Terminated

110 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute